FR2244468A1 - Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids - Google Patents

Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids

Info

Publication number
FR2244468A1
FR2244468A1 FR7327942A FR7327942A FR2244468A1 FR 2244468 A1 FR2244468 A1 FR 2244468A1 FR 7327942 A FR7327942 A FR 7327942A FR 7327942 A FR7327942 A FR 7327942A FR 2244468 A1 FR2244468 A1 FR 2244468A1
Authority
FR
France
Prior art keywords
contg
edible
antioxidants
vitamin
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7327942A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PASSWATER RICHARD US
Original Assignee
PASSWATER RICHARD US
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PASSWATER RICHARD US filed Critical PASSWATER RICHARD US
Priority to FR7327942A priority Critical patent/FR2244468A1/en
Publication of FR2244468A1 publication Critical patent/FR2244468A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)

Abstract

Food and animal feed supplements (pref. in the form of capsules) contain as essential ingredients (a) an edible antioxidant selected from vitamin C, vitamin E, other edible natural antioxidants, edible synthetic antioxidants, and their mixts. and (b) an edible sulphur-contg. peptide, amino acid and/or protein. The amt. of ingredient (a) should be such as to give a daily dosage of 100-5000 mg vitamin C, 30-2000 mg vitamin E, 10-1000 mg other natural antioxidants or 0.01-500 mg synthetic antioxidants. The amt. of ingredient (b) should be such as to give a daily consumption of 100-2000mg. All dosages are for a body weight of 54kg (average for adult humans). The supplements inhibit or retard the occurrence of all types of cancer, presumably due to an inhibition of free-radical processes. Medicaments for inhibiting skin cancers due to radiations or prolonged exposure to heat contain (a) an edible synthetic and/or natural antioxidant and (b) an edible S-contg. amino acid, protein or peptide in a form suitable for application to the skin.
FR7327942A 1973-07-31 1973-07-31 Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids Withdrawn FR2244468A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7327942A FR2244468A1 (en) 1973-07-31 1973-07-31 Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7327942A FR2244468A1 (en) 1973-07-31 1973-07-31 Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids

Publications (1)

Publication Number Publication Date
FR2244468A1 true FR2244468A1 (en) 1975-04-18

Family

ID=9123378

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7327942A Withdrawn FR2244468A1 (en) 1973-07-31 1973-07-31 Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids

Country Status (1)

Country Link
FR (1) FR2244468A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504802A1 (en) * 1981-04-29 1982-11-05 Hoffmann La Roche PHARMACEUTICAL PREPARATIONS WITH REGULATED RELEASE
WO1983001196A1 (en) * 1981-10-06 1983-04-14 Erland Johansson Mixture for human supply of selenium as a trace substance and the use thereof in solutions for storage of organs, in media for cell cultivation and in nutritive solutions for storage of blood components
WO1984000005A1 (en) * 1982-06-16 1984-01-05 Biofarm Fab Medicament Medicine for the treatment of the neoplazic disease
WO1984000006A1 (en) * 1982-06-18 1984-01-05 Bucuresti Medicamente Anti-tumour pharmaceutical preparation
EP0127012A2 (en) * 1983-05-30 1984-12-05 Suntory Limited Antimutagenic agent and a method of reducing mutagenicity
EP0141275A1 (en) * 1983-10-07 1985-05-15 M. Samir Amer Synergistic diet for the chemoprevention of cancer
EP0181142A2 (en) * 1984-10-31 1986-05-14 Justin D. Bennet A method of treating ulcerative colitis and colon cancer
WO1987003810A1 (en) * 1985-12-19 1987-07-02 Centre National De La Recherche Scientifique (Cnrs Nutrient compositions deprived of methionine and supplemented with homocysteine
EP0229652A2 (en) * 1986-01-16 1987-07-22 HENKEL CORPORATION (a Delaware corp.) Stabilized tocopherol in dry, particulate, free-flowing form
EP0347664A1 (en) * 1988-06-18 1989-12-27 Henkel Kommanditgesellschaft auf Aktien Topical cosmetic and pharmaceutical compositions
WO1991011117A2 (en) * 1990-02-05 1991-08-08 Board Of Regents, The University Of Texas System Dietary supplements comprising vitamins and minerals
EP0519876A1 (en) * 1991-06-18 1992-12-23 Istituti Fisioterapici Ospitalieri Pharmaceutical preparation to be used as adjuvant treatment of the seborrheic dermatitis even in HIV positive subjects
WO1994001006A2 (en) * 1992-07-04 1994-01-20 Bio-Nutritional Health Services Limited Composition for use as a food or food supplement
EP0607642A1 (en) * 1993-01-19 1994-07-27 PERRICONE, Nicholas V., Dr. Compositions for topical application to the skin for treatment and/or prevention of radiation-induced skin damage
WO1995013061A1 (en) * 1993-11-09 1995-05-18 Immunal Kft. Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504802A1 (en) * 1981-04-29 1982-11-05 Hoffmann La Roche PHARMACEUTICAL PREPARATIONS WITH REGULATED RELEASE
DE3215086A1 (en) * 1981-04-29 1982-11-18 F. Hoffmann-La Roche & Co AG, 4002 Basel PHARMACEUTICAL PREPARATIONS
WO1983001196A1 (en) * 1981-10-06 1983-04-14 Erland Johansson Mixture for human supply of selenium as a trace substance and the use thereof in solutions for storage of organs, in media for cell cultivation and in nutritive solutions for storage of blood components
WO1984000005A1 (en) * 1982-06-16 1984-01-05 Biofarm Fab Medicament Medicine for the treatment of the neoplazic disease
WO1984000006A1 (en) * 1982-06-18 1984-01-05 Bucuresti Medicamente Anti-tumour pharmaceutical preparation
EP0127012A2 (en) * 1983-05-30 1984-12-05 Suntory Limited Antimutagenic agent and a method of reducing mutagenicity
EP0127012A3 (en) * 1983-05-30 1987-05-27 Suntory Limited Antimutagenic agent and a method of reducing mutagenicity
EP0141275A1 (en) * 1983-10-07 1985-05-15 M. Samir Amer Synergistic diet for the chemoprevention of cancer
EP0181142A2 (en) * 1984-10-31 1986-05-14 Justin D. Bennet A method of treating ulcerative colitis and colon cancer
EP0181142A3 (en) * 1984-10-31 1988-03-16 Justin D. Bennet A method of treating ulcerative colitis and colon cancer
WO1987003810A1 (en) * 1985-12-19 1987-07-02 Centre National De La Recherche Scientifique (Cnrs Nutrient compositions deprived of methionine and supplemented with homocysteine
EP0232652A1 (en) * 1985-12-19 1987-08-19 Centre National De La Recherche Scientifique (Cnrs) Methionine-deficient nutritional compositions containing supplementary homocysteine
EP0229652A3 (en) * 1986-01-16 1987-10-14 Henkel Corporation Stabilized tocopherol in dry, particulate, free-flowing form
EP0229652A2 (en) * 1986-01-16 1987-07-22 HENKEL CORPORATION (a Delaware corp.) Stabilized tocopherol in dry, particulate, free-flowing form
EP0347664A1 (en) * 1988-06-18 1989-12-27 Henkel Kommanditgesellschaft auf Aktien Topical cosmetic and pharmaceutical compositions
WO1989012437A1 (en) * 1988-06-18 1989-12-28 Henkel Kommanditgesellschaft Auf Aktien Topical cosmetic and pharmaceutical preparation
AU646840B2 (en) * 1990-02-05 1994-03-10 Board Of Regents, The University Of Texas System Dietary supplements comprising vitamins and minerals
WO1991011117A2 (en) * 1990-02-05 1991-08-08 Board Of Regents, The University Of Texas System Dietary supplements comprising vitamins and minerals
WO1991011117A3 (en) * 1990-02-05 1991-09-19 Univ Texas Dietary supplements comprising vitamins and minerals
EP0519876A1 (en) * 1991-06-18 1992-12-23 Istituti Fisioterapici Ospitalieri Pharmaceutical preparation to be used as adjuvant treatment of the seborrheic dermatitis even in HIV positive subjects
US5290809A (en) * 1991-06-18 1994-03-01 Istituto Fisioterapici Ospitalieri Methods for the treatment of seborrheic dermatitis
WO1994001006A2 (en) * 1992-07-04 1994-01-20 Bio-Nutritional Health Services Limited Composition for use as a food or food supplement
WO1994001006A3 (en) * 1992-07-04 1994-03-31 Bio Nutritional Health Service Composition for use as a food or food supplement
EP0607642A1 (en) * 1993-01-19 1994-07-27 PERRICONE, Nicholas V., Dr. Compositions for topical application to the skin for treatment and/or prevention of radiation-induced skin damage
WO1995013061A1 (en) * 1993-11-09 1995-05-18 Immunal Kft. Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation
ES2094702A1 (en) * 1993-11-09 1997-01-16 Immunal Kft Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation

Similar Documents

Publication Publication Date Title
FR2244468A1 (en) Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids
EP1216024B1 (en) Formulation for menopausal women
US5536506A (en) Use of piperine to increase the bioavailability of nutritional compounds
ATE147592T1 (en) FOOD SUPPLEMENTS CONTAINING VITAMINS AND MINERALS
KR0136072B1 (en) Nutrition for persons under going radiation therapy and/or chemotherapy
Metta et al. Vitamin K deficiency in rats induced by the feeding of irradiated beef
CZ298587B6 (en) Two-phase preparation
Levander et al. Interactions of Methionine, Vitamin E, and Antioxidants in Selenium Toxicity in the Rat1
Butterworth Jr et al. Tropical sprue: a consideration of possible etiologic mechanisms with emphasis on pteroylpolyglutamate metabolism.
US7939115B2 (en) Dietary supplement and related method
US4883661A (en) Use of arginine as an lymphokine synergist
Tipton et al. A comparison of D-, L-, DL-methionine and methionine hydroxy analogue calcium in chick diets
Nockels et al. Effect of excessive dietary vitamin E on the chick
JP3257091B2 (en) Anti-skin cancer agent or food
US6923967B1 (en) Treatment of dyspepsia
Ronald Steriti Nutritional support for chronic myelogenous and other leukemias: a review of the scientific literature
US2875060A (en) Food composition and method of preserving same
Tinsley DDT Effect on Rats Raised on Alpha-protein Rations: Growth and storage of liver vitamin A
US2403473A (en) Therapeutic compositions
CA1221031A (en) Use of a cholecalciferol derivative
RU2143212C1 (en) Biologically-active additive
CA2853989C (en) Palm pollen for treatment of mucositis and inflammatory conditions
Ershoff Effects of diet on fish oil toxicity in the rat
Nir et al. Effect of dietary protein level and thyroxine on vitamin A absorption and on plasma proteins in chicks
Sari Nutritional therapy in the treatment of recurrent aphthous stomatitis: A literature review

Legal Events

Date Code Title Description
ST Notification of lapse